NOVO-B.CO vs. CBK.DE
NOVO-B.CO (Novo Nordisk A/S) and CBK.DE (Commerzbank AG) are both stocks. NOVO-B.CO operates in Biotechnology (Healthcare), while CBK.DE operates in Banks - Regional (Financial Services). Over the past 10 years, NOVO-B.CO returned 15.87%/yr vs 19.90%/yr for CBK.DE. At a 0.12 correlation, their price movements are largely independent.
Performance
NOVO-B.CO vs. CBK.DE - Performance Comparison
Loading charts...
Different Trading Currencies
NOVO-B.CO is traded in DKK, while CBK.DE is traded in EUR. To make them comparable, the CBK.DE values have been converted to DKK using the latest available exchange rates.
Returns By Period
In the year-to-date period, NOVO-B.CO achieves a -14.51% return, which is significantly lower than CBK.DE's 3.91% return. Over the past 10 years, NOVO-B.CO has underperformed CBK.DE with an annualized return of 15.87%, while CBK.DE has yielded a comparatively higher 19.90% annualized return.
NOVO-B.CO
- 1D
- -1.18%
- 1M
- -7.41%
- YTD
- -14.51%
- 6M
- -7.00%
- 1Y
- -42.63%
- 3Y*
- 2.27%
- 5Y*
- 19.11%
- 10Y*
- 15.87%
CBK.DE
- 1D
- 0.00%
- 1M
- 5.68%
- YTD
- 3.91%
- 6M
- 9.44%
- 1Y
- 34.16%
- 3Y*
- 58.94%
- 5Y*
- 43.41%
- 10Y*
- 19.90%
NOVO-B.CO vs. CBK.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NOVO-B.CO Novo Nordisk A/S | -14.51% | -46.40% | -9.59% | 205.34% | 31.49% | 79.08% | 15.29% | 36.17% | -6.15% | 39.57% |
CBK.DE Commerzbank AG | 3.91% | 135.79% | 49.50% | 24.41% | 32.07% | 26.91% | -4.97% | -1.66% | -53.70% | 72.92% |
Correlation
The correlation between NOVO-B.CO and CBK.DE is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Sep 3, 2007 | 0.12 |
The correlation between NOVO-B.CO and CBK.DE shifts across timeframes, from 0.05 (10 years) to 0.19 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NOVO-B.CO vs. CBK.DE — Risk / Return Rank
NOVO-B.CO
CBK.DE
NOVO-B.CO vs. CBK.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOVO-B.CO) and Commerzbank AG (CBK.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NOVO-B.CO | CBK.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.68 | ||
| Sortino ratioReturn per unit of downside risk | -2.38 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.17 | -0.30 |
| Calmar ratioReturn relative to maximum drawdown | -0.79 | 1.54 | -2.33 |
| Martin ratioReturn relative to average drawdown | -1.16 | 3.08 | -4.24 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NOVO-B.CO | CBK.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.79 | 0.89 | -1.68 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.33 | 1.07 | -0.74 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.36 | 0.48 | -0.12 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.78 | -0.12 | +0.90 |
Drawdowns
NOVO-B.CO vs. CBK.DE - Drawdown Comparison
The maximum NOVO-B.CO drawdown since its inception was -76.75%, smaller than the maximum CBK.DE drawdown of -97.82%. Use the drawdown chart below to compare losses from any high point for NOVO-B.CO and CBK.DE.
Loading charts...
Drawdown Indicators
| NOVO-B.CO | CBK.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.75% | -97.82% | +21.07% |
Max Drawdown (1Y)Largest decline over 1 year | -54.94% | -21.83% | -33.11% |
Max Drawdown (3Y)Largest decline over 3 years | -76.75% | -21.85% | -54.90% |
Max Drawdown (5Y)Largest decline over 5 years | -76.75% | -38.71% | -38.04% |
Max Drawdown (10Y)Largest decline over 10 years | -76.75% | -78.36% | +1.61% |
Current DrawdownCurrent decline from peak | -72.07% | -69.61% | -2.46% |
Average DrawdownAverage peak-to-trough decline | -11.25% | -86.51% | +75.26% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 36.82% | 10.96% | +25.86% |
Volatility
NOVO-B.CO vs. CBK.DE - Volatility Comparison
Novo Nordisk A/S (NOVO-B.CO) has a higher volatility of 10.59% compared to Commerzbank AG (CBK.DE) at 6.15%. This indicates that NOVO-B.CO's price experiences larger fluctuations and is considered to be riskier than CBK.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NOVO-B.CO | CBK.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.59% | 6.15% | +4.44% |
Volatility (6M)Calculated over the trailing 6-month period | 39.29% | 26.83% | +12.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.59% | 37.92% | +16.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.54% | 39.95% | +18.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.06% | 41.62% | +3.44% |
Dividends
NOVO-B.CO vs. CBK.DE - Dividend Comparison
NOVO-B.CO's dividend yield for the trailing twelve months is around 4.35%, more than CBK.DE's 2.96% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CBK.DE Commerzbank AG | 2.96% | 1.80% | 1.93% | 1.61% | 0.00% | 0.00% | 0.00% | 3.62% | 0.00% | 0.00% | 2.76% | 0.00% |
NOVO-B.CO Novo Nordisk A/S | 4.35% | 3.58% | 1.59% | 1.01% | 2.38% | 2.54% | 4.03% | 4.22% | 5.27% | 4.54% | 7.38% | 2.50% |
Financials
NOVO-B.CO vs. CBK.DE - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Commerzbank AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NOVO-B.CO and CBK.DE have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NOVO-B.CO and CBK.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer